← News

May 21, 2024

Avenio Selected for NVIDIA Inception Program

Avenio joins NVIDIA Inception Program to scale Gen AI powered drug development process to revolutionize BioPharma research, reasoning, and coordination. The program provides access to NVIDIA's cutting-edge AI computing platform and resources to accelerate enterprise-grade BioPharma solutions.

Ready to transform your next clinical trial?

Join clinical teams at top biopharma, CROs, and biotech using Avenio to cut protocol cycle times.